Clinova Pathlabs Private Limited, a active private limited company, was established on 18 February 2020 in Hyderabad, Telangana, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85300TG2020PTC139321. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.85 Cr.
Employing 156 professional, Its leadership includes Ramakrishna Yadav Dega (Director), Kumaraswamy Yedavally (Director), Pravin Kantaram Khutwad (Additional Director). Past directors included Kumaraswamy Yedavally, Rathore Rahul Dev Singh, Venkata Reddy Akumalla. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 113 Hmt Nagar, Keesara,Nagaram Medchal,Rangareddy,, Hyderabad, Telangana, 501401.
U85300TG2020PTC139321
139321
18 February 2020
₹2.00 Cr
₹1.85 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Clinova Pathlabs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Yadav Dega | Director | 03 Jun 2020 | Current |
| Kumaraswamy Yedavally | Director | 15 Mar 2021 | Current |
| Pravin Kantaram Khutwad | Additional Director | 28 Mar 2025 | Current |
| Rathore Rahul Dev Singh | Director | 22 Dec 2020 | Current |
| Venkata Reddy Akumalla | Director | 15 Mar 2021 | Current |
| Bhagatsingh Chinta | Director | 15 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clinova Pathlabs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.38% decrease. The company also saw a substantial fall in profitability, with a 348.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Clinova Pathlabs had a public holding of 99.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Clinova Pathlabs has a workforce of 156 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Clinova Pathlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinova Pathlabs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Clinova Pathlabs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Clinova Pathlabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity Pravin Kantaram Khutwad was appointed as a Additional Director was appointed as a Additional Director on 28 Mar 2025 & has been associated with this company since 9 months 6 days . was completed.
Gowrisetti Ramakrishna was appointed as a Additional Director was appointed as a Additional Director on 08 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The activity Kumaraswamy Yedavally was appointed as a Director was appointed as a Director on 15 Mar 2021 & has been associated with this company since 4 years 9 months . was completed.
Venkata Reddy Akumalla was appointed as a Director was appointed as a Director on 15 Mar 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The CIN of Clinova Pathlabs Private Limited is U85300TG2020PTC139321.
Clinova Pathlabs Private Limited is headquartered at Plot No 113 Hmt Nagar, Keesara,Nagaram Medchal,Rangareddy,, Hyderabad, Telangana, 501401.
Clinova Pathlabs Private Limited was incorporated on 18 February 2020.
The current directors of Clinova Pathlabs Private Limited are
The primary industry of Clinova Pathlabs Private Limited is Hospital And Medical Care.
Clinova Pathlabs Private Limited is unlisted.
The authorized capital of Clinova Pathlabs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.85 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX